871709-90-9 Usage
Uses
Used in Pharmaceutical Industry:
1H-Indazole-3,6-diamine is used as an intermediate in the synthesis of pharmaceuticals for its ability to inhibit parasitic asparagine synthetase, making it a candidate for the development of anti-parasitic drugs.
Used in Chemical Industry:
1H-Indazole-3,6-diamine is used in the manufacturing of fluorescent dyes and organic pigments, leveraging its chemical properties to produce a variety of colorants for different applications.
Used in Research and Development:
IDA is utilized in research for its potential applications in medicine and chemistry, allowing for the exploration of new drug candidates and the enhancement of existing compounds through its versatile chemical structure.
Check Digit Verification of cas no
The CAS Registry Mumber 871709-90-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,1,7,0 and 9 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 871709-90:
(8*8)+(7*7)+(6*1)+(5*7)+(4*0)+(3*9)+(2*9)+(1*0)=199
199 % 10 = 9
So 871709-90-9 is a valid CAS Registry Number.
InChI:InChI=1S/C7H8N4/c8-4-1-2-5-6(3-4)10-11-7(5)9/h1-3H,8H2,(H3,9,10,11)
871709-90-9Relevant articles and documents
BENZAZOLE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE AS AURORA KINASE INHIBITORS
-
Page/Page column 57-58, (2010/11/28)
The present invention relates to compounds and methods from the treatment of cancer. The invention provides compounds that inhibit Aurora kinase, pharmaceutical compositions comprising compounds that inhibit Aurora kinase, and methods for the treatment of cancer using the compounds of the presentation invention or pharmaceutical compositions comprising compounds of the present invention.
3-AMINOINDAZOLES
-
Page/Page column 56, (2008/06/13)
Novel 3-aminoindazoles of formula (I) are SGK-inhibitors and can be used for treating SGK-related diseases and illnesses such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, and generally any type of fibroses and inflammatory processes.
